Gene Therapy Vectors

Successful, safe gene therapy technologies often need equally safe and efficacious delivery vector to reach their intended target cells. Our lab focuses on technologies like lipid nanoparticles (LNPs) and adeno-associated viruses (AAV) to ascertain parameters such as biodistribution, minimum effective dose, immunogenicity and toxicity.